BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang D, Chai XQ, Hu SS, Pan F. Joint synovial macrophages as a potential target for intra-articular treatment of osteoarthritis-related pain. Osteoarthritis Cartilage 2021:S1063-4584(21)00977-8. [PMID: 34861384 DOI: 10.1016/j.joca.2021.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia H, Duan L, Yu P, Zhou Y, Liu R, Wang H. Digoxin ameliorates joint inflammatory microenvironment by downregulating synovial macrophage M1-like-polarization and its-derived exosomal miR-146b-5p/Usp3&Sox5 axis. Int Immunopharmacol 2022;111:109135. [PMID: 35987145 DOI: 10.1016/j.intimp.2022.109135] [Reference Citation Analysis]
2 Wang L, He C. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front Immunol 2022;13:967193. [DOI: 10.3389/fimmu.2022.967193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu Y, Lu T, Liu Z, Ning W, Li S, Chen Y, Ge X, Guo C, Zheng Y, Wei X, Wang H. Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Front Immunol 2022;13:936606. [DOI: 10.3389/fimmu.2022.936606] [Reference Citation Analysis]
4 Bai L, Su Y, Wang X, Bai B, Zhang C, Zhang L, Zhang G. Synovial Macrophages: Past Life, Current Situation, and Application in Inflammatory Arthritis. Front Immunol 2022;13:905356. [DOI: 10.3389/fimmu.2022.905356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Emmi A, Stocco E, Boscolo-berto R, Contran M, Belluzzi E, Favero M, Ramonda R, Porzionato A, Ruggieri P, De Caro R, Macchi V. Infrapatellar Fat Pad-Synovial Membrane Anatomo-Fuctional Unit: Microscopic Basis for Piezo1/2 Mechanosensors Involvement in Osteoarthritis Pain. Front Cell Dev Biol 2022;10:886604. [DOI: 10.3389/fcell.2022.886604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gao W, Shen L, Long DD, Pan TT, Wang D, Chai XQ, Hu SS. Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain. Int Immunopharmacol 2022;110:108921. [PMID: 35724606 DOI: 10.1016/j.intimp.2022.108921] [Reference Citation Analysis]